Sickness absence among female employees with migraine and co-existing conditions

Cephalalgia

Volumn 28, Issue 11, 2008, Pages 1136-1144

  Maki K ^a   Vahtera, J ^b   Virtanen, M ^b   Elovainio, M ^a   Pentti, J ^b   Keltikangas Jarvinen L ^a   Kivimaki M ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Migraine; Respiratory disorders; Sickness absence

Indexed keywords

TRIPTAN DERIVATIVE;

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATICS; MIGRAINE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SOCIAL STATUS;

ADOLESCENT; ADULT; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; LUNG DISEASES; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; SICK LEAVE; SOCIOECONOMIC FACTORS; TRYPTAMINES;

EID: 53549128636     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01649.x     Document Type: Article

References (37)

1. Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors, and comorbidities. Neurology 2001 56 (Suppl. 1 4 12.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 : 646 57.
3. Stovner LJ, Zwart J-A, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006 13 : 333 45.
4. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005 118 (Suppl. 1 3 10.
5. Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olensen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005 12 (Suppl. 1 1 27.
6. Berg J. Economic evidence in migraine and other headaches: a review. Eur J Health Econ 2004 12 (Suppl. 1 43 54.
7. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999 159 : 813 18.
8. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics 1998 13 : 667 76.
9. Edmeads J, Mackell JA. The economic impact of migraine: an analysis of direct and indirect costs. Headache 2002 42 : 501 9.
10. Dueland AN, Leira R, Burke TA, Hillyer EV, Bolge S. The impact of migraine on work, family, and leisure among young women - a multinational study. Curr Med Res Opin 2004 20 : 1595 604.
11. Fiane I, Haugland ME, Stovner LJ, Zwart J-A, Bovim G, Hagen K. Sick leave is related to frequencies of migraine and non-migrainous headache - the HUNT Study. Cephalalgia 2006 26 : 960 7.
12. Michel P, Dartigues JF, Duru G, Moreau J, Salamon R, Henry P. Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 1999 19 : 503 10.
13. Michel P, Dartigues J, Lindoulsi A, Heanry P. Loss of productivity and quality of life in migraine sufferers among French workers: results from the Gazel cohort. Headache 1997 37 : 71 8.
14. Mounstephen AH, Harrison RK. A study of migraine and its effects in a working population. Occup Med 1995 45 : 311 17.
15. Aamondt AH, Stovner LJ, Langhammer A, Hagen K, Zwart J-A. Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study. Headache 2007 47 : 204 12.
16. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache 2006 46 : 1327 33.
17. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005 18 : 305 10.
18. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2004 25 : 165 78.
19. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR. Association between migraine and asthma: matched case-control study. Br J Gen Pract 2002 52 : 723 7.
20. Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch Neurol 1990 47 : 1227 30.
21. Mäki K, Vahtera J, Virtanen M, Elovainio M, Keltikangas-Jarvinen L, Kivimäki M. Work stress and new-onset migraine in a female employee population. Cephalalgia 2007 28 : 18 25.
22. Koskenvuo M, Kaprio J, Rose RJ, Kesäniemi A, Sarna S, Heikkilä K, Langinvainio H. Hostility as a risk factor for mortality and ischemic heart disease in men. Psychosom Med 1988 50 : 330 40.
23. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. Stratified care vs. step care strategies for migraine. The Disability in Strategies of Care (DISC) Study: a randomized trial. JAMA 2000 284 : 2599 605.
24. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT agonists) in acute migraine treatment. Lancet 2001 358 : 1668 75.
25. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002 346 : 257 70.
26. Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, Maassen van den Brink A et al. Triptan Cardiovascular Safety Expert Panel. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache 2004 44 : 414 25.
27. Hosmer DW, Lemenshow S, May S. Applied survival analysis: regression modeling of time to event data, 2nd edn. New York : Wiley 2008.
28. Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006 22 : 1203 10.
29. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003 12 : 22 33.
30. van Poppel MN, de Wet HC, Koes BW, Smid T, Bouter LM. Measuring sick leave: a comparison of self-reported data on sick leave and data from company records. Occup Med 2002 52 : 485 90.
31. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
32. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 (Suppl. 7 1 96.
33. Carson ALP, Rose KM, Sanford CP, Ephross SA, Stang PE, Hunt KJ et al. Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the atherosclerosis risk in communities (ARIC) study. Headache 2004 44 : 20 8.
34. Weaver MB, Mackowiak JI, Solari PG. Triptan therapy impacts health and productivity. J Occup Environ Med 2004 46 : 812 17.
35. Mushet GR, Miller D, Clements B, Pait G, Gutterman DL. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache 1996 36 : 137 43.
36. Lofland JH, Johnson NE, Batenhorst AS, Nash DB. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Arch Intern Med 1999 159 : 857 63.
37. Bousser M-G, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005 4 : 533 42.